Introducing Amplified Chlamydia Testing from a Urine Specimen |
|
Chlamydia screening that's more conclusive, less intrusive |
|
A Non-Invasive Collection Method Featuring:
| • | Convenience of a urine specimen – more likely to be accepted by men, women and adolescent patients |
| • | High sensitivity – as much as 30% more sensitive than non-amplified screening tests1 |
| • | CDC recognition – amplified testing is the preferred method for the detection of chlamydia2 |
Over 3 Million Sexually Active Men, Women and Adolescents Will Become Infected with Chlamydia This Year.1 Help Reverse this Trend with Routine Annual Screening.
| • | CDC recommended - the latest CDC guidelines state that all sexually active people at high risk should be screened annually for STDs |
| • | Amplified testing - available in a range of collection options, Nucleic Acid Amplification Testing offers increased sensitivity and specificity, resulting in fewer false negatives |
50% of Men with Chlamydia are Asymptomatic.3
| • | Untreated chlamydia in men typically causes urethral infection, but may also result in prostatitis, urethral scarring, infertility or epididymitis |
| • | According to the CDC, successful infection testing programs should include comprehensive screening and treatment for women as well as for men4 |
75% of Women with Chlamydia are Asymptomatic.3
| • | Up to 40% of women with untreated chlamydia will develop pelvic inflammatory disease (PID), which is the critical link to infertility and potentially fatal tubal pregnancy4 |
| • | CDC guidelines recommend annual screening for high-risk patients and rescreening of women treated for chlamydia infection due to the increased risk of reinfection2 |
Online Resources for Healthcare Professionals
| • | Access our online Test Menu, to obtain test ordering codes and specimen requirements |
| • | Contact a sales representative to learn more about our testing services or to become a Quest Diagnostics client |
| • | Receive your free copy of the recently published International Handbook of Chlamydia |
| • | Our Test Selection and Interpretation Guide includes Test Highlights for gonorrhea and chlamydia, which feature information on the tests' clinical use, clinical background, methodology, specimen requirements and interpretive information |
| • | Read about the May 2002 CDC Guidelines for the Treatment of Sexually Transmitted Diseases |
| • | Read about type-specific testing for the herpes simplex virus (HSV), with HerpeSelect®' |
| • | View our Chlamydia trachomatis and Neisseria gonorrhoeae PCR Test Algorithm |
| • | View our Amplified CT/GC PCR Testing Specimen Collection, Storage and Transport Guide |
Online Information for Your Patients
Your patients can learn about health conditions and laboratory tests in our Patient Health Library.
Contact a Quest Diagnostics Sales Representative,
learn more about our testing services, and become a client
| • | Contact a physician sales representative |
| • | Contact a hospital sales representative or learn about our complete hospital offerings |
References
1 Black, Carolyn M. "Current Methods of Laboratory Diagnosis of Chlamydia trachomatis Infections," Clin Microbiol Rev, Jan 1997, p 160-184.
2 Centers for Disease Control and Prevention, Sexually Transmitted Diseases Treatment Guidelines 2002, MMWR 2002, 51 (No. RR-6).
3 Honey et al. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies, Sex Transm Infect, 2002, p 406-412.
4 Centers for Disease Control and Prevention, Fact Sheet, Chlamydia in the United States, April 2001.
